BASTIAN; Jolie Anne
Patent Applications and Registrations
Patent applications and USPTO patent grants for BASTIAN; Jolie Anne.The latest application filed is for "selective estrogen receptor degraders".
Company Profile
8.29.21
- BASTIAN; Jolie Anne - Indianapolis IN
- Bastian; Jolie Anne - Beech Grove IN
Patent Activity
| Patent | Date |
|---|---|
| Selective Estrogen Receptor Degraders App 20210403480 - BASTIAN; Jolie Anne ; et al. | 2021-12-30 |
| Selective estrogen receptor degraders Grant 11,117,902 - Bastian , et al. September 14, 2 | 2021-09-14 |
| Selective Estrogen Receptor Degraders App 20200347073 - BASTIAN; Jolie Anne ; et al. | 2020-11-05 |
| 1-tetrahydropyranylcarbonyl-2,3-dihydro-1H-indole compounds for treating cancer Grant 10,759,786 - Bastian , et al. Sep | 2020-09-01 |
| Selective estrogen receptor degraders Grant 10,654,866 - Bastian , et al. | 2020-05-19 |
| Selective Estrogen Receptor Degraders App 20200017516 - BASTIAN; Jolie Anne ; et al. | 2020-01-16 |
| Pyrazolylaminobenzimidazole derivatives as JAK inhibitors Grant 10,344,018 - Bastian , et al. July 9, 2 | 2019-07-09 |
| Pyrazolylaminobenzimidazole derivatives as JAK inhibitors Grant 10,323,019 - Bastian , et al. | 2019-06-18 |
| Pyrazolylaminobenzimidazole Derivatives As Jak Inhibitors App 20190177300 - Bastian; Jolie Anne ; et al. | 2019-06-13 |
| 1-tetrahydropyranylcarbonyl-2,3-dihydro-ih-indole Compounds For Treating Cancer App 20190161477 - BASTIAN; Jolie Anne ; et al. | 2019-05-30 |
| Pyrazolylaminobenzimidazole Derivatives As Jak Inhibitors App 20180325873 - Bastian; Jolie Anne ; et al. | 2018-11-15 |
| 2,3-dihydro-1H-indole compounds Grant 9,872,853 - Bastian , et al. January 23, 2 | 2018-01-23 |
| 2,3-dihydro-1h-indole Compounds App 20170354641 - Bastian; Jolie Anne ; et al. | 2017-12-14 |
| Tetrasubstituted pyridazine hedgehog pathway antagonists Grant 8,507,490 - Bastian , et al. August 13, 2 | 2013-08-13 |
| Tetrasubstituted pyridazines hedgehog pathway antagonists Grant 8,445,493 - Bastian , et al. May 21, 2 | 2013-05-21 |
| Disubstituted phthalazine hedgehog pathway antagonists Grant 8,404,687 - Bastian , et al. March 26, 2 | 2013-03-26 |
| Tetrasubstituted Pyridazine Hedgehog Pathway Antagonists App 20110263602 - Bastian; Jolie Anne ; et al. | 2011-10-27 |
| Disubstituted Phthalazine Hedgehog Pathway Antagonists App 20110190304 - Bastian; Jolie Anne ; et al. | 2011-08-04 |
| Tetrasubstituted Pyridazines Hedgehog Pathway Antagonists App 20110178093 - Bastian; Jolie Anne ; et al. | 2011-07-21 |
| Kinase inhibitors Grant 7,652,015 - Bastian , et al. January 26, 2 | 2010-01-26 |
| Kinase Inhibitors App 20080269244 - Bastian; Jolie Anne ; et al. | 2008-10-30 |
| Certain glycine derivatives as factor Xa inhibitors for use in the treatment of thrombotic disorders Grant 7,297,706 - Wiley , et al. November 20, 2 | 2007-11-20 |
| .beta..sub.3 adrenergic agonists Grant 7,265,127 - Bastian , et al. September 4, 2 | 2007-09-04 |
| .beta..sub.3 adrenergic agonists Grant 7,253,181 - Bastian , et al. August 7, 2 | 2007-08-07 |
| .beta..sub.3 adrenergic agonists Grant 7,241,772 - Bastian , et al. July 10, 2 | 2007-07-10 |
| .beta.3 adrenergic agonists Grant 7,208,505 - Sall , et al. April 24, 2 | 2007-04-24 |
| 3-Substituted oxindole .beta.3 agonists Grant 7,205,407 - Bastian , et al. April 17, 2 | 2007-04-17 |
| CERTAIN GLYCINE DERIVATIVES AS FACTOR Xa INHIBITORS FOR USE IN THE TREATMENT OF THROMBOTIC DISORDERS App 20070072869 - Wiley; Michael Robert ; et al. | 2007-03-29 |
| 3-substituted oxindole .beta.3 agonists Grant 7,087,635 - Sall , et al. August 8, 2 | 2006-08-08 |
| Certain glycine derivatives as factor Xa inhibitors for use in the treatment of thrombotic disorders Grant 7,078,415 - Wiley , et al. July 18, 2 | 2006-07-18 |
| .beta..sub.3 Adrenergic agonists Grant 7,071,208 - Bastian , et al. July 4, 2 | 2006-07-04 |
| Beta 3 Adrenergic Agonists App 20060142329 - Bastian; Jolie Anne ; et al. | 2006-06-29 |
| Beta 3 Adrenergic Agonists App 20060142327 - Bastian; Jolie Anne ; et al. | 2006-06-29 |
| Beta 3 Adrenergic Agonists App 20060142328 - Bastian; Jolie Anne ; et al. | 2006-06-29 |
| 3-Substituted oxindole beta3 agonists App 20050159473 - Sall, Daniel Jon ; et al. | 2005-07-21 |
| 3-substituted oxindole .beta.-3 agonists Grant 6,911,463 - Sall , et al. June 28, 2 | 2005-06-28 |
| Beta 3 adrenergic agonists App 20050080110 - Sall, Daniel Jon ; et al. | 2005-04-14 |
| 3-substituted oxindole beta3 agonists App 20050020617 - Bastian, Jolie Anne ; et al. | 2005-01-27 |
| Beta 3 adrenergic agonists App 20050020618 - Bastian, Jolie Anne ; et al. | 2005-01-27 |
| Certain glycine derivatives as factor xa inhibitors for use in the treatment of thrombotic disorders App 20040249155 - Wiley, Michael Robert ; et al. | 2004-12-09 |
| 3-substituted oxindole beta-3 agonists App 20040242668 - Sall, Daniel Jon ; et al. | 2004-12-02 |
| Substituted tricyclics Grant 6,713,645 - Bach , et al. March 30, 2 | 2004-03-30 |
| Antithrombotic agents Grant 6,620,837 - Sall , et al. September 16, 2 | 2003-09-16 |
| Antithrombotic agents Grant 6,265,416 - Bastian , et al. July 24, 2 | 2001-07-24 |
| Antithrombotic diamines Grant 6,251,921 - Bastian , et al. June 26, 2 | 2001-06-26 |
| Substituted tricyclics Grant 6,177,440 - Bach , et al. January 23, 2 | 2001-01-23 |
| Antithrombotic diamines Grant 6,025,382 - Bastian , et al. February 15, 2 | 2000-02-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 